Goldman Sachs’s Treace Medical Concepts TMCI Stock Holding History
Bought
Maintained
Sold
Other funds holding TMCI
GA
Goldman Sachs's TMCI Position: Q3 2026 in Review
Goldman Sachs increased its Treace Medical Concepts (TMCI) stake by 21% in Q3 2026, buying an estimated $473K and bringing the position to 597,572 shares worth $2.65M. The position accounts for ﹤0.01% of the portfolio, ranked #4463.
Goldman Sachs first reported a position in TMCI in Q2 2021 and has held it in 20 quarters since. The position peaked at $4.51M in Q4 2023. 115 funds tracked by Wall St. Rank hold TMCI as of Q3 2026.
- Goldman Sachs held 597,572 shares of Treace Medical Concepts worth $2.65M as of Q3 2026.
- Goldman Sachs bought 105,456 Treace Medical Concepts shares in Q3 2026, an estimated $473K.
- Treace Medical Concepts made up ﹤0.01% of Goldman Sachs's portfolio in Q3 2026, its #4463 holding.
- Goldman Sachs first reported a position in Treace Medical Concepts in Q2 2021 and has held it in 20 quarters since.
- Goldman Sachs's Treace Medical Concepts position peaked at $4.51M in Q4 2023.
- 115 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2026.
Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.